XML 81 R58.htm IDEA: XBRL DOCUMENT v3.22.1
Research and Collaboration Arrangements - Additional Information (Details) - USD ($)
1 Months Ended 12 Months Ended
Jan. 31, 2014
Dec. 31, 2021
Dec. 31, 2020
Aug. 31, 2019
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]        
Deferred revenue   $ 5,090,000 $ 19,812,000  
Revenue recognized   15,100,000 3,200,000  
uniQure        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]        
Deferred revenue   3,661,000 4,396,000  
Due from related parties   $ 0 0  
uniQure | uniQure Agreement        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]        
Collaborative arrangement, initial research term 3 years      
Upfront payments received $ 200,000      
Options to purchase ordinary shares 609,744      
Ordinary shares vesting period 3 years      
Fair value of options $ 10,600,000      
Fair value of non monetary consideration of intellectual property right       $ 5,100,000
uniQure | uniQure Agreement | Minimum        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]        
Deferred revenue, estimated performance period   1 year    
uniQure | uniQure Agreement | Maximum        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]        
Contingent payments entitled to receive for achievement of research and development milestones $ 5,000,000.0      
Deferred revenue, estimated performance period   2 years    
uniQure | Amended uniQure Agreement        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]        
Revenue recognized   $ 700,000 700,000  
Remaining performance obligations   $ 3,700,000 $ 4,400,000  
uniQure | Amended uniQure Agreement | Maximum        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]        
Contingent payments eliminated       $ 5,000,000.0